Featured Articles

  1. Guide To PUPSIT And Annex 1 In Aseptic Processing 12/5/2024

    Pre-use, post-sterilization integrity testing (PUPSIT) ensures filters remain undamaged and effective during aseptic manufacturing. Discover how you can successfully perform PUPSIT with proven solutions.

  2. Aseptic Filling Solution Enhances Sterility Assurance for Pharma Manufacturer 11/21/2024

    Emergent BioSolutions upgraded its Winnipeg site with the Cytiva SA25 aseptic filling workcell to improve sterility assurance, product flexibility, and regulatory compliance for CGT manufacturing.

  3. Keeping The Momentum In Pandemic Preparedness 10/22/2024

    Learn about the partnership between the Prairie HUB and Cytiva to create RNA vaccines to target potential pandemic viruses with the aim of redefining global pandemic preparedness.

  4. How Is Additive Manufacturing Delivering On Sustainability Goals? 10/22/2024

    One of the key concerns for many biopharmaceutical companies is minimizing environmental impact. Learn about additive manufacturing and the significant advantages it offers to biomanufacturers.

  5. Addressing The Challenges Of Late-Stage Aseptic Manufacturing 10/15/2024

    Gain insight into the current landscape of filling and late-stage manufacturing from a survey of 78 professionals from top companies in the industry.

  6. A Risk-Based Approach To Validation Studies For Sterilizing-Grade Filtration And Single-Use Systems 10/3/2024

    One way to address risk related to product quality is by implementing a Question-Based Review approach. Read on to learn about this approach and its advantages.

  7. Biopharma's Battle With Scope 3 Emissions 9/3/2024

    Given the numerous stakeholders involved throughout a product's lifecycle and the limited direct control companies have, how can biopharma organizations effectively measure and manage Scope 3 emissions?

  8. 2024 Biopharma Sustainability Review Findings 9/3/2024

    What actions are biopharma leaders worldwide taking to enhance sustainability? What challenges are they encountering? And how can the broader industry learn from the companies paving the way?

  9. Eco-Design Yields Sustainability Gains — Why Is It So Hard? 9/3/2024

    Explore some of the biggest obstacles companies are encountering and what is already being done to move the industry closer to significant sustainability progress and environmental achievements.

  10. The Business Case For Sustainability ― From Industry Resilience To Bottom Line Impact 9/3/2024

    Explore key insights into how sustainability efforts are influencing business outcomes from a survey that collected data from 800 pharma and biopharma executives across 18 countries.